✦ LIBER ✦

Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis

✍ Scribed by Hammond, S.P.; Martin, S.T.; Roberts, K.; Gabardi, S.; Fuhlbrigge, A.L.; Camp, P.C.; Goldberg, H.J.; Marty, F.M.; Baden, L.R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for late-onset cytomegalovi

✍ A.A. Boudreault; H. Xie; R.M. Rakita; J.D. Scott; C.L. Davis; M. Boeckh; A.P. Li 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Antiviral dosing and efficacy for prophy

✍ Cochrane, A. B. 📂 Article 📅 2006 🏛 American Society of Health-System Pharmacists 🌐 English ⚖ 103 KB

Impact of targeted oral ganciclovir prop

✍ T. Shah; W.K. Lai; D. Mutimer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Acyclovir prophylaxis of cytomegalovirus

✍ A Vila; L.L Guirado; A Balius; M Dı́az; E Baró; M Olaya; M Andrade; I Agraz; R S 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Cytomegalovirus disease among donor-posi

✍ Dimitra Mitsani; M. Hong Nguyen; Eun J. Kwak; Fernanda P. Silveira; Aniket Vadne 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 347 KB

Late-Onset Cytomegalovirus (CMV) in Lung

✍ Schoeppler, K. E.; Lyu, D. M.; Grazia, T. J.; Crossno, J. T.; Vandervest, K. M.; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB